Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Current treatments for alopecia show no significant long-term benefits.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The herbal hair oil made from various plants might be a good alternative to synthetic hair loss treatments.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

The new follicular unit extraction treatment effectively treats severe hair loss in Asian men, giving natural-looking results with few side effects.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

A scalp infection was treated successfully, leading to full hair regrowth.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Laser therapy may effectively treat persistent scalp inflammation.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

A man's scalp infection, mistaken for bacterial, was actually a rare fungal infection treated successfully with antifungal medication.